Saturday, September 12, 2026
  • Politics
  • Lifestyle
  • Business
  • Medical
  • Shop
No Result
View All Result
  • Politics
  • Lifestyle
  • Business
  • Medical
  • Shop
No Result
View All Result
No Result
View All Result
Home Medical Marijuana

Congress’ Leading Marijuana Prohibitionist Trails In Latest Poll

by NORML
November 5, 2018
in Medical Marijuana, Politics
0
Congress’ Leading Marijuana Prohibitionist Trails In Latest Poll
0
SHARES
4
VIEWS
Share on FacebookShare on Twitter

by Paul Armentano, NORML Deputy Director November 5, 2018

Texas Republican and ardent marijuana prohibitionist Pete Sessions trails by four points in his re-election bid, according to polling data released yesterday. According to the survey results, Sessions is behind Democratic challenger Colin Allred by a margin of 46 percent to 42 percent in the race for Texas’ 32nd Congressional District.

As a member of Congress, Sessions has been one of the nation’s most vocal and powerful forces against our efforts to enact sensible marijuana policy reforms. Speaking publicly on the issue earlier this year, Sessions opined: “Marijuana is an addictive product, and the merchants of addiction make it that way. They make it to where our people, our young people, become addicted to marijuana and keep going.”

As I wrote last month in my ‘Marijuana and the midterms” op-ed in The Hill, “Pete Sessions has used his position as Chairman of the House Rules Committee to block House floor members from voting on over three-dozen marijuana-related amendments during his leadership tenure.” His actions have almost single-handedly killed a number of popular, bipartisan-led reforms — such as facilitating medical cannabis access to military veterans and amending federal banking laws so that licensed marijuana businesses are treated like other legal industries.

Representative Sessions received an ‘F’ grade in NORML’s latest Congressional Scorecard. By contrast, his Democratic challenger received a B+ grade as a result of his stated support for cannabis decriminalization and medical marijuana access.

Texas’ 32nd Congressional District represents the city of Garland and the northeastern section of Dallas.

Views: 628
Previous Post

No Reason To Relent

Next Post

The Most Impactful Cannabis Studies of All Time

NORML

Related Posts

Trump delays Hemp THC Ban

Trump delays Hemp THC Ban

by Graham Cooper
September 6, 2026
0

A bill that has provisions to delay the recriminalizing of certain hemp that contains THC has been signed by the...

Ron DeSantis misappropriated funds to anti-cannabis PAC

Ron DeSantis misappropriated funds to anti-cannabis PAC

by Graham Cooper
September 6, 2026
0

When legal marijuana was on the Florida ballot in 2024, Governor Ron DeSantis worked hard to make sure the measure...

Over 200,000 Marijuana Possession Arrests in the U.S. Signal Persistent Enforcement Challenges

Over 200,000 Marijuana Possession Arrests in the U.S. Signal Persistent Enforcement Challenges

by Keegan MacDonald
August 29, 2026
0

The Persistence of Marijuana Possession Arrests Amid Legal ShiftsMore than two hundred thousand individuals were arrested for marijuana possession in...

Full Transcript of Rescheduling Hearing Now Available

Full Transcript of Rescheduling Hearing Now Available

by Graham Cooper
August 27, 2026
0

With the decision by the judge coming imminently, the entire transcript of the multi-day hearing has been released to the...

Next Post
The Most Impactful Cannabis Studies of All Time

The Most Impactful Cannabis Studies of All Time

Marijuana IPOs Set to Reshape the Market as NYSE and Nasdaq Eye Cannabis Listings

Marijuana IPOs Set to Reshape the Market as NYSE and Nasdaq Eye Cannabis Listings

September 7, 2026
How Medical Cannabis is Impacting Pain, Sleep, and Mood in Older Adults

How Medical Cannabis is Impacting Pain, Sleep, and Mood in Older Adults

September 7, 2026
Trump delays Hemp THC Ban

Trump delays Hemp THC Ban

September 6, 2026
ADVERTISEMENT
Sign up for the PP Newsletter

Categories

  • Age Restrictions
  • Air Travel
  • All Categories
  • American Culture
  • Animal Health
  • Anxiety Relief
  • Ballot Initiative
  • Bioplastics
  • Bipartisan Bill
  • Bipartisan Politics
  • Business
  • Canada
  • Cancer
  • Cancer Care
  • Cancer Treatment
  • Cannabinoid Receptors
  • Cannabinoids
  • cannabis
  • Cannabis Brands
  • Cannabis Business
  • Cannabis Culture
  • Cannabis Extraction
  • Cannabis Finance
  • Cannabis Health Risks
  • Cannabis Industry
  • Cannabis Legalization
  • Cannabis Legislation
  • Cannabis Market
  • Cannabis Mergers
  • Cannabis Policy
  • Cannabis Reform
  • Cannabis Regulation
  • Cannabis Research
  • Cannabis Tax
  • Cannabis Tourism
  • Cannabis Travel
  • Cannabis Trends
  • Cannabis Use Disorder
  • Cardiovascular Effects
  • CB1 Receptor
  • CB2 Receptor
  • CBD
  • Cigarette Smoking
  • Colorado
  • Congress
  • Congressional Amendment
  • Consumer Health
  • Controlled Substances Act
  • Criminal Justice
  • Criminal Justice Reform
  • Culture
  • DEA
  • Deceptive Marketing
  • Democrats
  • Dispensary Closures
  • DMV Region
  • Donald Trump
  • Drug Policy
  • Employment Law
  • Endocannabinoid System
  • Entourage Effect
  • Environment
  • Farm Bill
  • FBI Data
  • FDA
  • Featured
  • Federal Cannabis Law
  • Federal Cannabis Policy
  • Federal Law
  • Federal Lawsuit
  • Federal Regulation
  • Georgia
  • Glioblastoma
  • Green Thumb Industries
  • Gun Rights
  • Health Research
  • Health Studies
  • Heart Health
  • Hemp
  • Hemp Regulation
  • Hemp-Derived THC
  • Illegal Market
  • Industry Risks
  • Insomnia
  • Investors
  • Jeff Sessions
  • Job Loss
  • John Fetterman
  • John Hickenlooper
  • Kratom
  • Law Enforcement
  • Lawmakers
  • Legal Cannabis Industry
  • Legal Compliance
  • Legal Precedent
  • Legalization
  • Legislation
  • Lifestyle
  • Lower Back Pain
  • Marijuana
  • Marijuana Arrests
  • Marijuana Clemency
  • Marijuana Descheduling
  • Marijuana Extracts
  • Marijuana IPOs
  • Marijuana Legalization
  • Marijuana Policy
  • Marijuana Reform
  • Marijuana Regulation
  • Marijuana Safety
  • Marijuana Use
  • Marijuana Users
  • Marijuana Withdrawal
  • Maryland
  • Massachusetts
  • Medical
  • Medical Cannabis
  • Medical Claims
  • Medical Marijuana
  • Medical Research
  • Mental Health
  • Michael Bennet
  • Michigan Cannabis
  • MJBizDaily
  • Mood Disorders
  • MSOs
  • Nasdaq
  • New Jersey
  • Nightmares
  • North Carolina
  • NYSE
  • Oklahoma
  • Older Adults
  • Opioid Reduction
  • Packaging
  • Pain Management
  • Patient Care
  • Pets
  • Police Search
  • Policy
  • Politics
  • Potent Cannabis
  • Pre-rolls
  • Product Safety
  • Psychedelics
  • PTSD
  • Public Education
  • Public Health
  • Public Listings
  • Public Safety
  • Rand Paul
  • Recreational Marijuana
  • Regulation
  • Regulatory Challenges
  • Regulatory Compliance
  • Retail Strategy
  • Second Amendment
  • Sharon Stone
  • Sleep Disorders
  • Small Business
  • SNDL
  • Social Equity
  • State Budget
  • State Cannabis Officials
  • State Legalization
  • State Legislation
  • Substance Use
  • Supreme Court
  • Sustainability
  • Symptom Management
  • Terpenes
  • Testosterone
  • THC
  • THC Potency
  • THC Products
  • Trump Administration
  • TSA
  • U.S. Senate
  • uncategorized
  • Underage Cannabis Use
  • Uplisting
  • US Cannabis
  • US Cannabis Market
  • US Politics
  • US Study
  • USPS
  • Veterans
  • Veterans Affairs
  • Virginia
  • World Cup 2024
  • Young Men

Recent Posts

  • Marijuana IPOs Set to Reshape the Market as NYSE and Nasdaq Eye Cannabis Listings
  • How Medical Cannabis is Impacting Pain, Sleep, and Mood in Older Adults

Browse by Tag

420 cannabis Edibles Legalization marijuana NORML THC

AFFILIATES

© Pot Portal. All rights reserved.

No Result
View All Result

© Pot Portal. All rights reserved.